Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-03-24Clinical Trial Update: BEtter Control of Blood Pressure in Hypertensive pAtients Monitored Using the HOTMAN® sYstem [Phase 3]
A Phase 3 trial evaluating the HOTMAN system for better blood pressure control in hypertensive patients has completed.
-
FDA approval · 2015-03-23FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for the fixed-dose combination of amlodipine and atorvastatin, manufactured by Prasco Laboratories. …
-
FDA label_change · 2015-03-23FDA Approved: CARDIZEM LA — Supplemental Application (Bausch Health US LLC)
FDA approved a supplemental labeling application for Cardizem LA (diltiazem hydrochloride extended-release tablets) from Bausch Health US LL…
-
FDA approval · 2015-03-23FDA Approved: NORVASC — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Norvasc (amlodipine besylate) submitted by Viatris Specialty LLC to update the labeling.
-
CLINICAL_TRIALS trial_result · 2015-03-23Clinical Trial Update: The Effects on Blood Pressure Control, Pulse Wave Velocity, as Well as Safety and Tolerability of Felodipine Sustained Release in Chinese Patients. [NA]
A completed clinical trial in Chinese patients assessed how felodipine sustained release affected blood pressure control and pulse wave velo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-03-20FDA Approved: ATENOLOL — Supplemental Application (Ipca Laboratories Limited)
FDA approved a supplemental application for Atenolol from Ipca Laboratories Limited under the ANDA, granting approval for changes related to…
-
FDA approval · 2015-03-20FDA Approved: TERAZOSIN — Supplemental Application (Jubilant Cadista Pharmacuticals Inc.)
FDA approved a supplemental application for terazosin hydrochloride from Jubilant Cadista Pharmaceuticals Inc., related to the generic teraz…
-
CLINICAL_TRIALS research · 2015-03-19Clinical Trial Update: Identify Possible Errors on Home Use Blood Pressure Monitors by Usability Reasoning
This completed clinical trial investigated potential user errors when using home blood pressure monitors by applying usability reasoning to …
-
CLINICAL_TRIALS research · 2015-03-19Clinical Trial Update: Mobile Application to Improve Nutritional Counseling Provided by Primary Care Physicians for Hypertension. [NA]
A completed clinical trial evaluated a mobile application designed to improve nutritional counseling provided by primary care physicians for…
-
FDA approval · 2015-03-18FDA Approved: METOPROLOL TARTRATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for METOPROLOL TARTRATE by Mylan Pharmaceuticals Inc., confirming approval of the generic product.
-
CLINICAL_TRIALS withdrawal · 2015-03-17Clinical Trial Update: Sympathetic Nerve Activity in Renal Failure [Phase 4]
A Phase 4 clinical trial examining sympathetic nerve activity in chronic kidney disease with hypertension has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-03-13Clinical Trial Update: Ginseng and Ginkgo Biloba Effects on Cognition as Modulated by Cardiovascular Reactivity [EARLY_Phase 1]
This early-phase 1 study from Sunway University investigated whether ginseng and Ginkgo biloba influence cognition and whether cardiovascula…
-
CLINICAL_TRIALS trial_result · 2015-03-11Clinical Trial Update: Telmisartan and Hydrochlorothiazide Antihypertensive Treatment Study in High Sodium Intake Population [NA]
A completed clinical trial evaluated the antihypertensive combination of telmisartan and hydrochlorothiazide in people with high sodium inta…
-
CLINICAL_TRIALS research · 2015-03-10Clinical Trial Update: L-citrulline Supplementation, Cold Exposure, & Post-Exercise Muscle Ischemia [Phase 1, Phase 2]
A Phase 1/2 trial evaluating L-citrulline supplementation combined with cold exposure on post-exercise muscle ischemia in hypertension; the …
-
CLINICAL_TRIALS trial_result · 2015-03-10Clinical Trial Update: Monetary Incentives and Intrinsic Motivation to Sustain Hypertension Control [NA]
This entry notes the completion of a UCLA-led clinical trial examining whether monetary incentives can sustain intrinsic motivation to maint…
-
CLINICAL_TRIALS trial_result · 2015-03-10Clinical Trial Update: AF Ablation With or Without ROX Coupler Study [Phase 4]
Phase 4 clinical trial update evaluating atrial fibrillation ablation with or without the ROX Coupler, sponsored by Neil Sulke; current stat…
-
CLINICAL_TRIALS trial_result · 2015-03-10Clinical Trial Update: Whole Body Vibration Combined With L-citrulline Supplementation on Cardiovascular Function and Body Composition [NA]
A clinical trial evaluating whole body vibration with L-citrulline supplementation for cardiovascular function and body composition has comp…
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: Hypertension Study: Multinational Torasemide Trial in Mild to Moderate Hypertension. [Phase 4]
This clinical trial update notes the completion of a multinational Phase 4 torasemide trial in adults with mild to moderate hypertension.
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: Impact of Pacing Site and AV Delay on Blood Pressure in Hypertensive Patients [NA]
Completed clinical trial evaluating how pacing site and AV delay influence blood pressure in adults with hypertension.
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: Tinnitus and Arterial Hypertension
This clinical trial update covers a study involving tinnitus, hearing loss, and hypertension sponsored by Faculdade de Medicina de Valenca. …
-
CLINICAL_TRIALS trial_result · 2015-03-03Clinical Trial Update: Effects of Linagliptin on Endothelial- , Renal-, and Retinal Function in Patients With Hypertension and Albuminuria [Phase 3]
Phase 3 trial update evaluating the effects of linagliptin on endothelial, renal, and retinal function in patients with hypertension and alb…
-
FDA approval · 2015-03-02FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for the generic combination irbesartan and hydrochlorothiazide manufactured by Hikma Pharmaceuticals…
-
FDA approval · 2015-03-02FDA Approved: MOEXIPRIL HYDROCHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's Moexipril hydrochloride under a supplemental ANDA, expanding the availability of a generic Moexipril product.
-
CLINICAL_TRIALS trial_result · 2015-02-27Clinical Trial Update: The Effects of Rimonabant, on Weight and Metabolic Risk Factors [Phase 2]
Phase 2 trial investigating the effects of rimonabant on weight and metabolic risk factors; study terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2015-02-27Clinical Trial Update: A Study to Investigate the Influence of MK0859 on Blood Pressure (MK-0859-012)(COMPLETED) [Phase 1]
A Phase 1 study evaluating MK0859's influence on ambulatory blood pressure has completed.